Yuki Hirose

p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent metabolic reprogramming

Tetsuya Saito, Yoshinobu Ichimura, Keiko Taguchi et al. · Nature Communications · 2016 · 372 citations · Full text

Medicine, Molecular Biology, Oncology +17

A simple quantitative bradykinesia test in MPTP-treated mice.

N Ogawa, Yuki Hirose, S Ohara et al. · PubMed · 1985 · 337 citations

Medicine, Neuroscience, Pharmacology +16

MPTP-Induced Parkinsonian Model in Mice: Biochemistry, Pharmacology and Behavior

N. Ogawa, Kiminao Mizukawa, Yuki Hirose et al. · European Neurology · 2008 · 129 citations

Life Sciences, Neuroscience, Pharmacology +17

Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.

Sayaka Shimizu, Ritsuko Yoshioka, Yuki Hirose et al. · The Journal of Experimental Medicine · 1989 · 105 citations · Full text

Life Sciences, Cell Biology, Immunology +9

Randomized phase II study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Research Organization PC-01 study)

Masato Ozaka, Yuji Matsumura, Hiroshi Ishii et al. · Cancer Chemotherapy and Pharmacology · 2012 · 85 citations

Medicine, Oncology, Pharmacology +9